About Rcri
RCRI was established in 2009 and operates from Minneapolis, United States. Focus is placed on the medical device, in vitro diagnostics, biologics, and combination product industries. Integrated services encompass clinical research, regulatory and quality systems, health economics and reimbursement, as well as compliance support. Operations involve strategic consulting to facilitate development and market entry for these sectors.
- Headquarter Minneapolis, United States
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Rcri
Detailed funding history for Rcri
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Rcri
Rcri has secured backing from 1 investor. Prominent investors backing the company include Covance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRO offering comprehensive drug development solutions from drug discovery to life cycle management
|
Locked | Locked | Locked |
Investor details for Rcri
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rcri
Investment portfolio details for Rcri
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rcri
Detailed financials for Rcri
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rcri Comparisons
Peer comparison for Rcri
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rcri
Detailed competitors of Rcri
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rcri
Complete news archive for Rcri
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rcri
Rcri was founded in 2009.
Rcri is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
RCRI was established in 2009 and operates from Minneapolis, United States. Focus is placed on the medical device, in vitro diagnostics, biologics, and combination product industries. Integrated services encompass clinical research, regulatory and quality systems, health economics and reimbursement, as well as compliance support. Operations involve strategic consulting to facilitate development and market entry for these sectors.
Rcri has 1 investor. Key investors include Covance.